Tonix Pharmaceuticals is currently enrolling participants in a Phase 3 trial for posttraumatic stress disorder (PTSD).
For more information, please visit www.recoverystudy.com or www.clinicaltrials.gov (NCT03841773).
|09/04/19||8-K||Current report filing||6|
|08/30/19||8-K||Current report filing||3|
|08/23/19||S-1||General form of registration statement for all companies including face-amount certificate companies||47|
|08/23/19||8-K||Current report filing||66|
|08/21/19||8-K||Current report filing||178|
|08/21/19||8-K||Current report filing
|08/20/19||8-K||Current report filing
|08/12/19||8-K||Current report filing||8|
|08/12/19||10-Q||Quarterly report pursuant to Section 13 or 15(d)||63|
|08/02/19||8-K||Current report filing||5|